1	Analysis	Analysis	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	modulation	modulation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	transcriptional	transcriptional	_	_	_	_	_	_	_
7	activity	activity	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	myelopoiesis	myelopoiesis	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	leukemogenesis	leukemogenesis	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Acute	acute	_	_	_	_	_	_	_
2	myeloid	myeloid	_	_	_	_	_	_	_
3	leukemia	leukemia	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	AML	AML	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	still	still	_	_	_	_	_	_	_
9	associated	associate	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	mortality	mortality	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	60	60	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	80	80	_	_	_	_	_	_	_
17	%	%	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	AML	AML	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	characterized	characterize	_	_	_	_	_	_	_
4	by	by	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	block	block	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	myeloid	myeloid	_	_	_	_	_	_	_
9	differentiation	differentiation	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	transcription	transcription	_	_	_	_	_	_	_
3	factors	factor	_	_	_	_	_	_	_
4	PU.1	PU.1	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	C/EBPalpha	C/EBPalpha	_	_	_	_	_	_	_
7	are	be	_	_	_	_	_	_	_
8	responsible	responsible	_	_	_	_	_	_	_
9	for	for	_	_	_	_	_	_	_
10	normal	normal	_	_	_	_	_	_	_
11	myeloid	myeloid	_	_	_	_	_	_	_
12	differentiation	differentiation	_	_	_	_	_	_	_
13	from	from	_	_	_	_	_	_	_
14	stem	stem	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	monocytes	monocyte	_	_	_	_	_	_	_
18	or	or	_	_	_	_	_	_	_
19	granulocytes	granulocyte	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	particular	particular	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	PU.1	PU.1	_	_	_	_	_	_	_
5	induces	induce	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	macrophage	macrophage	_	_	_	_	_	_	_
10	colony-stimulating	colony-stimulating	_	_	_	_	_	_	_
11	factor	factor	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	M-CSF	M-CSF	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	receptor	receptor	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	development	development	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	monocytes	monocyte	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	whereas	whereas	_	_	_	_	_	_	_
23	C/EBPalpha	C/EBPalpha	_	_	_	_	_	_	_
24	increases	increase	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	expression	expression	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	granulocyte	granulocyte	_	_	_	_	_	_	_
30	colony-stimulating	colony-stimulating	_	_	_	_	_	_	_
31	factor	factor	_	_	_	_	_	_	_
32	(	(	_	_	_	_	_	_	_
33	G-CSF	G-CSF	_	_	_	_	_	_	_
34	)	)	_	_	_	_	_	_	_
35	receptor	receptor	_	_	_	_	_	_	_
36	and	and	_	_	_	_	_	_	_
37	leads	lead	_	_	_	_	_	_	_
38	to	to	_	_	_	_	_	_	_
39	mature	mature	_	_	_	_	_	_	_
40	granulocytes	granulocyte	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	AML	AML	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	chromosomal	chromosomal	_	_	_	_	_	_	_
5	aberrations	aberration	_	_	_	_	_	_	_
6	result	result	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	oncoproteins	oncoprotein	_	_	_	_	_	_	_
9	such	such	_	_	_	_	_	_	_
10	as	as	_	_	_	_	_	_	_
11	AML1/ETO	AML1/ETO	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	PML/RARalpha	PML/RARalpha	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	or	or	_	_	_	_	_	_	_
16	activated	activate	_	_	_	_	_	_	_
17	Ras	ras	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	which	which	_	_	_	_	_	_	_
20	can	can	_	_	_	_	_	_	_
21	deregulate	deregulate	_	_	_	_	_	_	_
22	genes	gene	_	_	_	_	_	_	_
23	important	important	_	_	_	_	_	_	_
24	for	for	_	_	_	_	_	_	_
25	normal	normal	_	_	_	_	_	_	_
26	myelopoiesis	myelopoiesis	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	AML1/ETO	AML1/ETO	_	_	_	_	_	_	_
4	can	can	_	_	_	_	_	_	_
5	bind	bind	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	transcription	transcription	_	_	_	_	_	_	_
9	factor	factor	_	_	_	_	_	_	_
10	C/EBPalpha	C/EBPalpha	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	inhibit	inhibit	_	_	_	_	_	_	_
13	C/EBPalpha-dependent	c/ebpalpha-dependent	_	_	_	_	_	_	_
14	transcription	transcription	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	block	block	_	_	_	_	_	_	_
18	granulocytic	granulocytic	_	_	_	_	_	_	_
19	differentiation	differentiation	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	AML1/ETO	AML1/ETO	_	_	_	_	_	_	_
4	can	can	_	_	_	_	_	_	_
5	also	also	_	_	_	_	_	_	_
6	synergize	synergize	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	transcription	transcription	_	_	_	_	_	_	_
10	factor	factor	_	_	_	_	_	_	_
11	AML1	aml1	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	enhance	enhance	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	activity	activity	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	M-CSF	M-CSF	_	_	_	_	_	_	_
19	receptor	receptor	_	_	_	_	_	_	_
20	promoter	promoter	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	On	on	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	other	other	_	_	_	_	_	_	_
4	hand	hand	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	PML/RARalpha	PML/RARalpha	_	_	_	_	_	_	_
8	fusion	fusion	_	_	_	_	_	_	_
9	protein	protein	_	_	_	_	_	_	_
10	causes	cause	_	_	_	_	_	_	_
11	transcriptional	transcriptional	_	_	_	_	_	_	_
12	repression	repression	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	recruiting	recruit	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	nuclear	nuclear	_	_	_	_	_	_	_
17	corepressor	corepressor	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	N-CoR	N-CoR	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	histone	histone	_	_	_	_	_	_	_
22	deacetylase	deacetylase	_	_	_	_	_	_	_
23	complex	complex	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	DNA	dna	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	which	which	_	_	_	_	_	_	_
29	results	result	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	decreased	decrease	_	_	_	_	_	_	_
32	histone	histone	_	_	_	_	_	_	_
33	acetylation	acetylation	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	a	a	_	_	_	_	_	_	_
36	repressive	repressive	_	_	_	_	_	_	_
37	chromatin	chromatin	_	_	_	_	_	_	_
38	organization	organization	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	Here	here	_	_	_	_	_	_	_
2	we	we	_	_	_	_	_	_	_
3	describe	describe	_	_	_	_	_	_	_
4	methods	method	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	investigate	investigate	_	_	_	_	_	_	_
7	whether	whether	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	how	how	_	_	_	_	_	_	_
10	signaling	signaling	_	_	_	_	_	_	_
11	agonists	agonist	_	_	_	_	_	_	_
12	induce	induce	_	_	_	_	_	_	_
13	myeloid	myeloid	_	_	_	_	_	_	_
14	differentiation	differentiation	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	how	how	_	_	_	_	_	_	_
17	oncoproteins	oncoprotein	_	_	_	_	_	_	_
18	might	might	_	_	_	_	_	_	_
19	cause	cause	_	_	_	_	_	_	_
20	AML	AML	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	modulating	modulate	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	activity	activity	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	transcription	transcription	_	_	_	_	_	_	_
27	factors	factor	_	_	_	_	_	_	_
28	that	that	_	_	_	_	_	_	_
29	are	be	_	_	_	_	_	_	_
30	pivotal	pivotal	_	_	_	_	_	_	_
31	for	for	_	_	_	_	_	_	_
32	normal	normal	_	_	_	_	_	_	_
33	myeloid	myeloid	_	_	_	_	_	_	_
34	development	development	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	Copyright	Copyright	_	_	_	_	_	_	_
2	1999	1999	_	_	_	_	_	_	_
3	Academic	Academic	_	_	_	_	_	_	_
4	Press	Press	_	_	_	_	_	_	_
5	.	.	_	_	_	_	_	_	_

